Kishiyama Shirley S, Leahy Marjorie J, Zitzelberger Tracy A, Guariglia Robin, Zajdel Daniel P, Calvert James F, Kaye Jeffrey A, Oken Barry S
Department of Neurology, Oregon Health and Science University, Portland, Oregon, USA.
Altern Ther Health Med. 2005 May-Jun;11(3):48-53.
To analyze dietary supplement usage data from 494 older adults, aged 65 to 101 years.
Community dwellers living independently of institutionalized care.
All dietary supplements, including botanicals, were recorded to aid in assessing the health status of older adults.
Data verified from labels, not from self-report.
Of the participants, 70.6% used dietary supplements. Women took supplements more often than men, and usage decreased with age. A greater percentage, 67.4%, of the non-metropolitan oldest-old took supplements, compared to 56.7% of the metropolitan oldest-old. The greatest usage, 89.7%, was in the metropolitan young-olds. All of these percentages exceed those for comparable age groups in national representative surveys.
Dietary supplement usage by older adults in these studies in Oregon exceeded that in other reports and may reflect high interest in complementary and alternative medicine. This report confirms the results of other studies showing that elderly adults, particularly women, use dietary supplements more than other segments of the US population. Researchers and clinicians should be aware of this pattern and potential conflicts with research design or treatment regimen intended for older people.
分析494名年龄在65至101岁之间的老年人的膳食补充剂使用数据。
独立生活而非接受机构护理的社区居民。
记录所有膳食补充剂,包括植物性补充剂,以帮助评估老年人的健康状况。
1)224名参与一项跟踪俄勒冈州南部非都市地区克拉马斯县85岁及以上老人(高龄老人)健康状况研究的个体;2)134名居住在波特兰大都市区的高龄老人参与者,他们参加了一项银杏叶提取物(GBE)预防痴呆症的随机临床试验;3)136名年龄在65 - 85岁(低龄老人)之间、同样来自波特兰地区的参与者,他们参加了一项关于瑜伽和运动对认知影响的研究。
数据从标签核实,而非来自自我报告。
参与者中,70.6%使用膳食补充剂。女性服用补充剂的频率高于男性,且使用率随年龄增长而降低。非都市地区高龄老人中服用补充剂的比例更高,为67.4%,而都市地区高龄老人的这一比例为56.7%。使用率最高的是都市地区的低龄老人,为89.7%。所有这些比例均超过全国代表性调查中可比年龄组的比例。
俄勒冈州这些研究中老年人的膳食补充剂使用率高于其他报告,这可能反映出对补充和替代医学的高度兴趣。本报告证实了其他研究的结果,即老年人,尤其是女性,比美国其他人群更多地使用膳食补充剂。研究人员和临床医生应意识到这种模式以及与针对老年人的研究设计或治疗方案可能存在的冲突。